Evidence map›Paper›PMID 31189996›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.

Julia A Bridge, Janos Sumegi, Mihaela Druta, Marilyn M Bui, Evita Henderson-Jackson, Konstantinos Linos, Michael Baker, Christine M Walko, Sherri Millis, Andrew S Brohl

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. EWSR1::BEND2 fusion sarcoma in bone: a report of two rare cases.Virchows Archiv : an international journal of pathology · 2025
    Article
  8. Emerging round cell sarcomas in children.Virchows Archiv : an international journal of pathology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. A case of pelvicRadiology case reports · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Small round cell sarcomas.Nature reviews. Disease primers · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Julia A BridgeDivision of Molecular Pathology, The Translational Genomics Research Institute/Ashion, Phoenix, AZ, USA. jbridge@unmc.edu.
Janos SumegiDivision of Molecular Pathology, The Translational Genomics Research Institute/Ashion, Phoenix, AZ, USA.
Mihaela DrutaSarcoma Department, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Marilyn M BuiSarcoma Department, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-4963-2255
Evita Henderson-JacksonSarcoma Department, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Konstantinos LinosDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, NH, USA.ORCID http://orcid.org/0000-0001-9462-652X
Michael BakerDepartment of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, NH, USA.
Christine M WalkoPersonalized Medicine Institute, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Sherri MillisFoundation Medicine, Inc, Cambridge, MA, USA.
Andrew S BrohlSarcoma Department, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Moffitt Cancer Center · USDartmouth–Hitchcock Medical Center · USTranslational Genomics Research Institute · USFoundation Medicine (United States)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular diagnostics of sarcoma subtypes commonly involve the identification of characteristic oncogenic fusions. EWSR1-PATZ1 is a rare fusion partnering in sarcoma, with few cases reported in the literature. In the current study, a series of 11 cases of EWSR1-PATZ1 fusion positive malignancies are described. EWSR1-PATZ1-related sarcomas occur across a wide age range and have a strong predilection for chest wall primary site. Secondary driver mutations in cell-cycle genes, and in particular CDKN2A (71%), are common in EWSR1-PATZ1 sarcomas in this series. In a subset of cases, an extended clinical and histopathological review was performed, as was confirmation and characterization of the fusion breakpoint revealing a novel intronic pseudoexon sequence insertion. Unified by a shared gene fusion, EWSR1-PATZ1 sarcomas otherwise appear to exhibit divergent morphology, a polyphenotypic immunoprofile, and variable clinical behavior posing challenges for precise classification.

Indexed as

AdolescentAdultAged, 80 and overBrain NeoplasmsChildFemaleHumansKruppel-Like Transcription FactorsMaleMiddle AgedOncogene Proteins, FusionRepressor ProteinsRNA-Binding Protein EWSSarcomaSoft Tissue NeoplasmsYoung AdultEWSR1 protein, humanKruppel-Like Transcription FactorsOncogene Proteins, FusionPATZ1 protein, humanRepressor ProteinsRNA-Binding Protein EWS

Identifiers

PMID31189996
OpenAlexW2949584415

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.